CELLCARTA

Live / Registered — Registered (as of 18 Jun 2024)

What this means for you

Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90112472
Registration number
7422358
Mark type
Stylized text
Filed
13 Aug 2020
Published for opposition
19 Jan 2021
Registered
18 Jun 2024
Attorney of record
Keith Toms, Esq.

Goods and services

  • Class 042 — Scientific and technological services: Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific research and development in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; immune monitoring, and genetic profiling for research and development purposes; scientific research and development in the field of mass cytometry, cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; providing laboratory testing services in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Software as a service (SAAS) services featuring software for informatics, bioinformatics; software as a service (SAAS) services featuring software for clinical trial data acquisition, validation, and analysis; Software as a service (SAAS) services featuring software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Software as a service (SAAS) services featuring software for cell cytometry; Software as a service (SAAS) services featuring software for managing information related to clinical trials
  • Class 044 — Medical, beauty and agricultural services: Genetic testing for medical purposes; Consulting services in the fields of diagnostic medical testing; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; immune monitoring, and genetic profiling for medical and diagnostic purposes
  • Class 045 — Legal and security services: Regulatory compliance consulting in the fields of pharmaceuticals and clinical diagnostics; Advice and consultancy on food, drug, and medical device regulatory matters; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical device

Owner

Prosecution history

  • 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
  • 13 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 13 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 19 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 18 Mar 2024 — USE AMENDMENT FILED
  • 18 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
  • 20 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 19 Sept 2023 — SOU EXTENSION 5 GRANTED
  • 12 Sept 2023 — SOU EXTENSION 5 FILED
  • 19 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 12 Sept 2023 — SOU TEAS EXTENSION RECEIVED
  • 14 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Mar 2023 — SOU EXTENSION 4 GRANTED
  • 10 Mar 2023 — SOU EXTENSION 4 FILED

View this trademark record on Marksy